iTeos Therapeutics, Inc. ITOS

Full chart Compare
Set alert

Price alert · ITOS

All alert types
10.15 0.00 (+0.00%)

At closeAug 29, 2025, 4:00 PM EDT

10.15 Day range 10.15

52-week range unavailable

YTD
+32.16%
1 year
-40.82%

Revenue & Expenses

Other Income → Expenses: $39.19MExpenses → Selling, General & Admin: $49.08MExpenses → Research & Development: $145.45MExpenses → Income Tax: $14.07MGross Profit → Expenses: $35.00MRevenue → Gross Profit: $35.00MNet Loss → Expenses: $134.41MOther Income$39.19MGross Profit$35.00MNet Loss$134.41MExpenses$208.60MSelling, General & Admin$49.08MResearch & Development$145.45MIncome Tax$14.07MRevenue$35.00M

Latest period ending Dec 31, 2024 · select a line to chart its full history

ITOS annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
35.00M12.60M267.63M344.77M0
35.00M12.60M267.63M344.77M0
-159.53M-151.10M126.32M244.90M-45.24M
-134.41M-112.64M96.65M214.52M-38.03M
-3.32-3.152.565.68-2.88
ITOS annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
142.43M251.45M285.04M848.84M336.45M
686.98M667.59M754.99M884.71M344.56M
96.68M92.36M91.66M331.89M21.36M
5.10M6.06M4.67M5.34M0
590.29M575.23M663.33M552.82M323.20M
ITOS annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-98.18M-103.76M-111.19M513.14M-25.18M
-131.15M72.66M-446.06M-1.24M-377.00K
122.24M1.11M1.98M3.66M340.34M
-1.63M-2.97M-938.00K-1.18M-356.00K
-109.02M-33.59M-563.80M512.38M316.46M